Diabetes Mellitus Screening

The ADA proposes healthcare-setting screening for all asymptomatic adults aged 35 years or older.Oxford AcademicOxford AcademicGuidelines and Recommendations for Laboratory Analysis ... Available search evidence does not provide a complete risk-factor-based earlier-screening algorithm, pregnancy screening protocol, rescreening interval, or stopping rule; consult current ADA Standards for those decisions.

ADA and AAP recommend screening asymptomatic youth for type 2 diabetes and prediabetes.publications aappublications aapScreening and Diagnosis of Prediabetes and Diabetes in ... The supplied evidence does not specify the pediatric eligibility criteria or testing interval; use current pediatric guidance to determine which children and adolescents meet risk-based screening criteria.

Diabetes may be diagnosed by elevated venous plasma glucose or elevated hemoglobin A1C.Oxford AcademicOxford AcademicExecutive Summary: Guidelines and Recommendations for ... The accepted diagnostic thresholds cited in the supplied guidance are fasting plasma glucose at least 126 mg/dL (7.0 mmol/L), 2-hour plasma glucose at least 200 mg/dL (11.1 mmol/L) after a standard 75-g OGTT, or A1C at least 6.5%.IDSAIDSAPrimary Care Guidance for Persons With HIV

A1C, fasting plasma glucose, and 2-hour OGTT are all proposed screening options for asymptomatic adults.Oxford AcademicOxford AcademicGuidelines and Recommendations for Laboratory Analysis ... Test selection should be driven by clinical practicality and the likelihood of misleading A1C interpretation. A1C alone identifies only a minority of diabetes cases identified collectively by A1C and glucose-based criteria, underscoring that discordance between assays is clinically meaningful rather than exceptional.Diabetes JournalsDiabetes Journals2. Classification and Diagnosis of Diabetes: Standards of ...

When A1C and fasting glucose are discordant in people with HIV, the cited ADA approach is to repeat the abnormal test and diagnose diabetes only if the repeat result remains above the diagnostic cutoff.IDSAIDSAPrimary Care Guidance for Persons With HIV This confirmation principle is particularly important when screening detects isolated, modest abnormalities rather than unequivocal hyperglycemia.

A random glucose greater than 200 mg/dL in people with HIV should trigger further evaluation with fasting blood glucose.IDSAIDSAPrimary Care Guidance for Persons With HIV The supplied sources do not provide a general-population random-glucose diagnostic pathway or symptom-based exception to confirmation; follow current ADA diagnostic guidance for those scenarios.

Among people with HIV, A1C is highly specific but insensitive for diabetes diagnosis and can underestimate diabetes risk.IDSAIDSAPrimary Care Guidance for Persons With HIV The HIVMA/IDSA guidance reports that ADA standards recommend against using A1C to diagnose diabetes in people with HIV receiving ART; after ART initiation, use plasma glucose criteria for diagnosis.IDSAIDSAPrimary Care Guidance for Persons With HIV

Obtain random or fasting glucose and A1C before starting ART. At entry to HIV care and annually thereafter, obtain either random or fasting glucose; if random glucose is abnormal, obtain fasting glucose.IDSAIDSAPrimary Care Guidance for Persons With HIV A1C may still be followed in patients with established diabetes, but correlate it with measured glucose because ART may cause over- or underestimation on an individual basis.IDSAIDSAPrimary Care Guidance for Persons With HIV

The principal goal of type 1 diabetes screening programs in youth is to reduce diabetic ketoacidosis at diagnosis and support research participation.publications aappublications aapScreening Programs for Type 1 Diabetes in Youth However, type 1 diabetes screening is still conducted primarily in research-based settings, and real-world testing remains inconsistent.publications aappublications aapType 1 Diabetes Screening in Pediatrics

An analysis from the ASK study suggests that autoantibody screening may be cost-effective in areas with high diabetic ketoacidosis rates, but the supplied evidence does not establish a universal U.S. population-screening recommendation, testing panel, or surveillance schedule.Oxford AcademicOxford AcademicEstablishing Screening Programs for Presymptomatic Type 1 ...